CCM · NYSE · ·
3,32 US$-4,5 %cierre 29 sept
Del propio 6-K de la empresa.
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China.
La propia descripción de la empresa, tal como aparece al pie de la publicación.
La cita y la descripción de la empresa proceden del 6-K con resultados que Concord Medical Services Holdings Ltd presentó el 26 de septiembre de 2025; la tabla se elabora a partir de sus informes trimestrales. Leer la publicación en EDGAR Las cotizaciones están ajustadas por splits y dividendos.
Concord Medical Services Holdings Ltd no tiene ninguna transcripción de conferencia de resultados disponible.